Live news related to SANOFI stock (FR0000120578): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The stock of the French pharmaceutical company closed at 78.03 euros this Tuesday, January 20, 2026, amid marked volatility. Following several downwar…
UBS établit une recommandation neutre sur Sanofi ce vendredi 16 janvier 2026.
Deutsche Bank révise à la baisse son objectif de cours sur Sanofi ce vendredi 16 janvier 2026.
Sanofi's stock is down by 0.92% at 80.88 euros midday this Friday, January 16, affected by a double downgrade in analyst recommendations. UBS and Deut…
Le PDG de Sanofi prévoit une faiblesse à court terme des ventes de vaccins aux Etats-Unis due à la rhétorique antivax et à une baisse de l'adoption. L…
The Chinese National Medical Products Administration has approved two Sanofi-licensed drugs, according to the company's statement. These are Myqorzo (…
Sanofi's stock has risen by 2.55% at midday on Wednesday, January 14, after testing its support threshold at 80.50 euros the previous day. This reboun…
Sanofi's stock closed down 2.32% at 80.50 euros this Tuesday, January 13, touching its support threshold at 80.60 euros. This challenging session come…
The European Commission has approved the marketing of Tzield (teplizumab), a treatment developed by Sanofi intended to delay the progression to stage …
The stock of the French pharmaceutical giant increased by 1.87% this Friday, January 9, closing at 84.44 euros after a session marked by renewed inves…
